Ikarian Capital, LLC Pliant Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.11 - $8.75 $373,208 - $794,543	-90,805 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.01 - $14.1 $28,691 - $57,711	4,093 Added 4.72%	90,805 $636,000
Q3 2021 Nov 15, 2021	SELL	$16.48 - $28.98 $362,362 - $637,212	-21,988 Reduced 20.23%	86,712 $1.46 Million
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $2.67 Million - $4.37 Million	108,700 New	108,700 $4.28 Million

169

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $532M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.